2Nettar K, Maas C. Facial filler and neurotoxin complications[J]. Facial Plast Surg, 2012,28(3) :288-293.
3Brin MF, Boodhoo T1, Pogoda JM, et al. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines : a metaanalysis of individual patient data from global clinical registration studies in 1678 participants[ J ]. J Am Acad Dermatol, 2009,61 (6) :961-970.
4Skaf GS, Domloj NT, Salameh JA, et al. Pseudoaneurysm of the superficial temporal artery : a complication of botulinum toxin injection [ J 1. Aes- thetic Plast Surg, 2012,36(4) :982-985.
5Prado A, Fuentes P, Guerra C, et al. Pseudoaneurysm of the frontal branch of the superficial temporal artery : an unusual complication after the in-jection of botox [ J ]. Plast Reconstr Surg, 2007,119 (7) :2334-2335.
6Isaac CR, Chalita MR, Pinto LD. Botox after Botox -a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports[J]. Arq Bras Oftalmol, 2012,75(3):213-214.
7Lee SJ, Kang JM, Kim YK, et al. Paradoxical bulging of muscle after injection of botulinum neurotoxin type A into hypertrophied masseter muscle[J]. J Dermatol, 2012,39(9) :804-805.
8Gaurav Bharti, Malcolm W, Markslisa R, et al. Patient satisfaction of dermal fillers and effect on utilization of invasive aesthetic treatment modali- ties at a university-based cosmetic center[ J]. Eur J Plast Surg, 2011,34:155-160.
9Haehach-Haram N, Gregori M, Kirkpatrick N, et al. Complications of facial fillers;resource implications for NHS hospitals [ J ]. BMJ Case Rep, 2013,28:2013.
10Narins RS, Jewell M, Rubin M, et al. Clinical conference:management of rare events following dermal fillers focal necrosis and angry red bumps[J]. Dermatol Surg, 2006,32(3) :426-434.
